New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
15:46 EDTNBYDoctor uses NovaBay product in flesh-eating disease treatment, SFGate says
Dr. John Crew has used NeutroPhase, a NovaBay Pharmaceuticals product approved for cleaning wounds, as part of a new technique he successfully implemented to treat necrotizing fasciitis, which is otherwise known as "flesh-eating disease," while trying to avoid the repeated surgeries typically associated with treatment of the condition, reported SFGate yesterday. Reference Link
News For NBY From The Last 14 Days
Check below for free stories on NBY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2014
07:03 EDTNBYNovaBay deploys i-Lid Cleanser sales force in U.S.
Subscribe for More Information
August 20, 2014
09:07 EDTNBYOn The Fly: Pre-market Movers
UP AFTER EARNINGS: PetSmart (PETM), up 2,1%... Staples (SPLS), up 2%... E-House (EJ), up 2.5%. HIGHER: Fairchild (FCS), up 4% after Bloomberg says Infineon (IFNNY) is near a deal to buy a U.S. semiconductor company for $2B... Amicus Therapeutics (FOLD), up 18.4% after reporting positive Phase 3 data from the Fabry study. DOWN AFTER EARNINGS: Lowe's (LOW), down 3%... Tarena (TEDU), down 9%... Leju (LEJU), down 4.2%... JA Solar (JASO), down 5%. LOWER: Hertz (HTZ), down 12.7% after downgraded at JPMorgan and Deutsche Bank following the company's decision to withdraw its FY14 guidance... NovaBay (NBY), down 35.2% after primary, secondary endpoints were not met in its NVC-422 study... RGS Energy (RGSE), down 14.9% after downgraded at Roth Capital following Q2 earnings results.
07:02 EDTNBYNovaBay announces primary, secondary endpoints not met in NVC-422 study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use